Soleno Therapeutics, Inc. (SLNO)
52.84
+0.06
(+0.11%)
USD |
NASDAQ |
Apr 30, 15:38
Soleno Therapeutics Total Assets (Quarterly) : 563.83M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 4.753B |
| Nektar Therapeutics | 280.41M |
| Forian, Inc. | 44.54M |
| Boston Scientific Corp. | -- |
| Integer Holdings Corp. | 3.411B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 113.72M |
| Shareholders Equity (Quarterly) | 450.12M |
| Debt to Equity Ratio | 0.1168 |
| Current Ratio | 5.798 |
| Net Debt Paydown Yield | -0.41% |